Daewoong Co., Ltd. Profile Avatar - Palmy Investing

Daewoong Co., Ltd.

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd.

Drug Manufacturers - General
KR, Hwaseong-si [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
44.23 43.83 32.87 35.02 45.77 40.07 39.07 45.38 45.81 44.48 46.38 46.22 50.50 53.00 50.93
Profit Margin
2.61 4.82 15.99 14.44 4.83 2.66 3.88 1.95 5.89 2.43 4.57 7.26 5.21 6.04 8.41
Operating Margin
12.75 13.45 18.44 14.21 11.52 8.80 8.00 6.01 7.52 6.97 7.87 11.05 8.17 12.22 10.79
EPS Growth
-42.22 61.71 33.69 2.32 -8.35 -41.99 62.24 -89.85 1,567.39 -54.89 105.78 64.55 -19.14 30.20 49.65
Return on Assets (ROA)
2.83 4.20 9.07 8.68 4.54 2.36 3.11 1.35 4.28 1.88 3.74 5.35 4.07 4.75 6.47
Return on Equity (ROE)
8.31 12.00 13.36 12.23 10.24 5.53 8.30 4.08 12.16 5.24 9.95 14.35 10.78 12.37 16.33
Return on Invested Capital (ROIC)
11.28 17.01 11.70 9.66 15.99 7.44 7.67 4.10 9.33 4.83 9.24 10.86 9.25 12.63 13.14
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
12.22 13.93 12.30 9.99 8.02 16.55 19.40 28.15 24.86 24.30 23.58 24.14 23.04 20.62 20.14
Debt/Equity
35.86 39.77 18.11 14.07 18.11 38.86 51.79 85.03 70.70 67.91 62.68 64.72 60.98 53.71 50.83
Debt/EBITDA
21.52 12.95 92.97 18.19 -25.59 78.44 115.51 301.66 170.47 192.23 212.87 122.96 184.44 113.45 127.03
Debt/Capitalization
26.39 28.46 15.34 12.34 15.33 27.99 34.12 45.95 41.42 40.45 38.53 39.29 37.88 34.94 33.70
Interest Debt per Share KRW
2,188.12 2,639.30 1,423.34 1,257.36 1,748.52 3,978.40 5,747.11 9,702.75 9,113.19 9,186.56 9,344.15 10,813.78 10,968.82 10,907.09 11,904.22
Debt Growth
-25.73 24.20 -45.29 -13.29 41.66 132.03 44.12 71.38 -6.79 0.46 1.70 12.73 0.45 -0.08 7.22
Liquidity
Current Ratio
201.59 179.66 129.45 159.70 308.30 414.85 344.38 263.26 255.96 191.95 268.62 227.42 164.99 184.97 124.82
Quick Ratio
150.19 130.41 95.68 110.77 200.96 293.84 241.03 179.84 167.26 116.90 180.02 158.60 116.51 123.38 73.83
Cash Ratio
27.33 41.83 21.57 43.87 74.28 60.74 56.58 40.01 48.14 24.87 23.91 53.53 24.25 36.92 23.40
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
401.22 343.41 504.88 424.80 297.92 338.65 329.17 250.36 244.58 238.15 292.99 287.99 300.30 251.09 252.76
Receivables Turnover
485.71 - - 415.63 565.38 694.43 637.33 570.39 494.39 552.19 575.13 563.31 653.98 723.29 689.39 797.69
Payables Turnover
488.33 415.13 433.09 565.96 851.66 1,016.22 1,102.60 745.16 989.45 1,054.43 874.40 914.47 905.63 885.31 857.08
Asset Turnover
108.52 87.11 56.74 60.12 93.89 88.45 80.23 69.18 72.56 77.33 81.87 73.76 78.16 78.62 76.93
Coverage
Interest Coverage
1,684.46 2,306.53 3,918.35 2,089.75 5,035.57 3,463.36 2,096.50 1,230.47 996.08 893.81 1,064.89 1,425.43 1,199.05 2,482.75 1,145.02
Asset Coverage
600 500 700 800 1,000 500 400 200 300 300 300 300 300 300 300
Cash Flow Coverage (CFGR)
136.68 32.09 17.73 54.27 119.58 27.87 31.08 4.54 38.38 11.73 35.21 32.78 29.89 33.49 42.23
EBITDA Coverage
2,300 2,700 3,000 2,300 6,900 4,900 3,100 2,000 1,700 1,500 1,500 1,900 1,600 2,600 1,400
Dividend Coverage
-200 -300 -1,200 -900 -400 -200 -400 -200 -800 - - -1,400 -2,200 -1,800 -2,400 -3,600
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
5.04 5.89 2.89 2.31 2.65 2.27 1.70 2.16 0.89 - - 0.77 0.20 0.33 0.51 0.49
Earnings Yield
12.75 22.05 36.36 21.91 12.04 6.19 8.01 5.22 7.69 3.98 11.17 4.66 6.10 12.52 17.92
Price/Earnings (P/E)
7.8463 4.5362 2.7505 4.5651 8.3056 16.1596 12.4862 19.1412 13.0041 25.1445 8.9565 21.4671 16.3879 7.9858 5.5801
Price/Book (P/B)
65.20 54.44 36.73 55.81 85.08 89.40 103.61 78.13 158.19 131.82 89.10 308.16 176.61 98.82 91.13
Price/Sales (P/S)
20.48 21.88 43.97 65.91 40.14 43.04 48.39 37.40 76.64 60.99 40.95 155.82 85.37 48.26 46.93
Price/Cash Flow (P/CF)
133.03 426.55 1,143.83 730.67 392.88 825.58 643.73 2,023.85 583.01 1,654.66 403.75 1,452.82 968.82 549.41 424.55
End of 003090.KS's Analysis
CIK: - CUSIP: - ISIN: KR7003090008 LEI: - UEI: -
Secondary Listings
003090.KS has no secondary listings inside our databases.